Singhvi Rahul Insider Trades

Insider Trading History

Track insider trading activity for Singhvi Rahul. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Codexis
Codexis CDXS
Director
Holding Value $147k 66,350 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$165k 66,350 shares
$2.48
$2.21
Codexis
Codexis CDXS
Director
Holding Value $303k 137,052 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$100k 40,983 shares
$2.44
$2.21
Codexis
Codexis CDXS
Director
Holding Value $212k 96,069 shares
Last Trade
Jun 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$100k 30,120 shares
$3.32
$2.21
Codexis
Codexis CDXS
Director
Holding Value $22.1k 10,000 shares
Last Trade
Nov 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16k 10,000 shares
$1.60
$2.21
Codexis
Codexis CDXS
Director
Holding Value $146k 65,949 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$100k 34,602 shares
$2.89
$2.21
Codexis
Codexis CDXS
Director
Holding Value $69.3k 31,347 shares
Last Trade
Sep 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 31,347 shares
$6.38
$2.21
ImmunoCellular Therapeutics,
ImmunoCellular Therapeutics, IMUC
Director
Holding Value $42.3k 156,750 shares
Last Trade
Jun 17, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.27
ImmunoCellular Therapeutics,
ImmunoCellular Therapeutics, IMUC
Director
Holding Value $4.05k 15,000 shares
Last Trade
Sep 18, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.27
ImmunoCellular Therapeutics,
ImmunoCellular Therapeutics, IMUC
Director
Holding Value $18.9k 70,000 shares
Last Trade
Jun 26, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.27
ImmunoCellular Therapeutics,
ImmunoCellular Therapeutics, IMUC
Director
Holding Value $13.8k 51,154 shares
Last Trade
Jun 13, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.27
ImmunoCellular Therapeutics,
ImmunoCellular Therapeutics, IMUC
Director
Holding Value $18.9k 70,000 shares
Last Trade
Sep 20, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.27
ImmunoCellular Therapeutics,
ImmunoCellular Therapeutics, IMUC
Director
Holding Value $20.3k 75,000 shares
Last Trade
Sep 24, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.27
ImmunoCellular Therapeutics,
ImmunoCellular Therapeutics, IMUC
Director
Holding Value $1.35k 5,000 shares
Last Trade
May 25, 2012 Sale
No data
No data
$0.27
Novavax
Novavax NVAX
President, CEO
Holding Value $10.2M 1,210,001 shares
Last Trade
Mar 10, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.5M 250,000 shares
$50.00
$8.43
Novavax
Novavax NVAX
President, CEO
Holding Value $1.26M 150,000 shares
Last Trade
Mar 15, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.05M 150,000 shares
$47.00
$8.43
Novavax
Novavax NVAX
President, CEO
Holding Value $953k 113,104 shares
Last Trade
Jul 02, 2009 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.88M 50,000 shares
$57.60
$8.43
Novavax
Novavax NVAX
President, CEO
Holding Value $2.83M 336,138 shares
Last Trade
Jul 01, 2009 Sale (Open Market)Shares sold on the open market or in a private sale.
$12.1M 208,334 shares
$58.20
$8.43
Novavax
Novavax NVAX
President, CEO
Holding Value $3.13M 371,438 shares
Last Trade
Jul 01, 2009 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$17.5M 300,000 shares
$58.20
$8.43
Novavax
Novavax NVAX
President, CEO
Holding Value $1.48M 175,000 shares
Last Trade
Mar 05, 2009 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.96M 175,000 shares
$11.20
$8.43
Novavax
Novavax NVAX
President, CEO
Holding Value $1.87M 221,438 shares
Last Trade
Jul 31, 2008 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$798k 15,831 shares
$50.40
$8.43

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up